InnovAge Holding Corp. Common Stock (INNV) is a publicly traded Healthcare sector company. As of May 21, 2026, INNV trades at $7.82 with a market cap of $984.09M and a P/E ratio of -93.06. INNV moved +4.30% today. Year to date, INNV is +37.04%; over the trailing twelve months it is +77.12%. Its 52-week range spans $2.60 to $10.69. Analyst consensus is sell with an average price target of $7.00. Rallies surfaces INNV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
InnovAge Appoints Jennifer Browne as President and COO Effective June 8: InnovAge will install Jennifer Browne as President and COO on June 8, 2026, tasking her with overseeing market operations and support functions to drive consistency in execution, participant experience and compliance. Browne joins from Strive Health and previously led a value-based care portfolio of 1.2 million patients at Optum.
| Metric | Value |
|---|---|
| Price | $7.82 |
| Market Cap | $984.09M |
| P/E Ratio | -93.06 |
| EPS | $-0.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.69 |
| 52-Week Low | $2.60 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $949.17M |
| Net Income | $-15.47M |
| Gross Margin | 21.75% |
3 analysts cover INNV: 0 strong buy, 0 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $7.00.